Carla Kim received her PhD in Genetics from the University of Wisconsin-Madison and completed postdoctoral training at the Massachusetts Institute... » More

Carla Kim received her PhD in Genetics from the University of Wisconsin-Madison and completed postdoctoral training at the Massachusetts Institute of Technology. She currently serves as an Assistant Professor in the Stem Cell Program at Children's Hospital in Boston and the Genetics Department at Harvard Medical School. She is a member of the Harvard Stem Cell Institute and the Dana-Farber Harvard Cancer Center. Dr. Kim developed a method to isolate the first stem cell population from the adult murine lung, termed bronchioalveolar stem cells (BASCs). She also showed that BASCs are critically affected by an oncogenic K-ras mutation and may be the cell-of-origin of lung adenocarcinomas. Her current research focuses on the characterization of non-small cell lung cancer stem cells and normal lung stem cells. Dr. Kim is a member of the International Society for Stem Cell Research and the American Society for Cell Biology. Her research is currently funded through grants from the National Institutes of Health, the American Cancer Society, and the V Foundation for Cancer Research.

« Hide